ArticleFEBS letters2026
A Cre-dependent lentiviral vector for neuron subtype-specific expression of large proteins.
Article in FEBS letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Lentiviral vectors are powerful tools for long-term expression of large genes in the mammalian brain, but the palette of lentiviral tools available for targeting specific cell subpopulations is restricted. We describe a lentiviral vector for neuronal subtype-specific expression in Cre mouse lines. Combining a Cre-dependent flip excision switch with a GFP and a 2A self-cleaving peptide, it enables identification of living neurons expressing a gene of interest using fluorescence. We validated this vector by targeting neocortical interneuron types and midbrain dopaminergic neurons. Gene expression occurred exclusively in Cre-expressing neurons without altering their basic electrophysiological properties. This system has been designed to be flexible and easy to modify in order to target expression of any gene of interest in any cell subtype.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.